IN8bio, Inc.
IN8bio, Inc. (INAB) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
inab · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for IN8bio, Inc. (INAB) measures how much investors pay for each dollar of the company's trailing earnings. INAB's current PE ratio of N/A is calculated by dividing its stock price of $1.44 by its TTM earnings per share of -$4.34.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
IN8bio, Inc.You INAB | $7M | N/A | — | -$4.34 |
 Acurx Pharmaceuticals, Inc. ACXP | $3M | N/A | — | -$5.31 |
 Aprea Therapeutics, Inc. APRE | $5M | N/A | — | -$1.93 |
 Aptevo Therapeutics Inc. APVO | $11M | N/A | — | -$8230.43 |
 BioCardia, Inc. BCDA | $5M | N/A | — | -$1.23 |
 Galecto, Inc. GLTO | $34M | N/A | — | -$143.51 |
 HCW Biologics Inc. HCWB | $3M | N/A | — | -$3.79 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-4.44 | — | |
2024-12-31 FY2024 | — | $-0.57 | — | |
2023-12-31 FY2023 | — | $-1.00 | — | |
2022-12-31 FY2022 | — | $-1.36 | — | |
2021-12-31 FY2021 | — | $-0.78 | — | |
2020-12-31 FY2020 | — | $-0.44 | — | |
2019-12-31 FY2019 | — | $-0.27 | — | |
2018-12-31 FY2018 | — | $-0.11 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for IN8bio, Inc. (INAB) measures how much investors pay for each dollar of the company's trailing earnings. INAB's current PE ratio of N/A is calculated by dividing its stock price of $1.44 by its TTM earnings per share of -$4.34.
Frequently asked questions
INAB pe ratio · 6 questionsINAB's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.44 and TTM EPS of -$4.34. Data sourced from Financial Modeling Prep via INAB's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IN8bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09